Meeting
2022 ASCO Annual Meeting
A multicenter real-world study of tumor-derived DNA from cerebrospinal fluid in genomic profiling of NSCLC with central nervous system metastases.
Authors
Yongping Mu
Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, China
Yongping Mu , Wei Guo , Xia Zhang , Kai Wang , Mingming Yuan , Rongrong Chen , Jun Bai , Qun Hu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9087)
DOI
10.1200/JCO.2022.40.16_suppl.9087
Abstract #
9087
Poster Bd #
74
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
ctDNA detection in patients with brain metastases arising from solid tumors.
First Author: Laura Alder
Poster
2017 ASCO Annual Meeting
NGS to reveal heterogeneity between cerebrospinal fluid and plasma ctDNA among non-small cell lung cancer patients with leptomeningeal carcinomatosis.
First Author: Ben-Yuan Jiang
Poster
2024 ASCO Breakthrough
Outcomes of EGFR, ALK, ROS1, BRAF, MET, and RET mutated non-small cell lung cancer with brain metastases (NSCLC BM).
First Author: Xiaoyan Li
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu